A team of Japanese and German researchers has found the protein that helps activate the inflammasome following viral invasion.
Researchers at University Lyon have found a potential repurposing application of two market-approved rotavirus vaccines.
Swiss Polyphor AG and researchers from the University of Zurich have presented the mechanism of action of a new class of antibiotics.
Zealand Pharma A/S has acquired Encycle Therapeutics Inc, including a peptide therapeutics platform and library.
German researchers have found a novel way to induce iron-induced necrosis, a process which they want to turn against cancer.
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its October 2019 meeting.
A molecular transporter is critical for the proper maturation of neurons underlying neurodevelopmental disorders.
AI-driven drug repurposing company Healx Ltd (Cambridge, UK) raises US$56m in a Series B financing and launches global accelerator programme for orphan diseases.
The Netherlands Cancer Institute (NKI) has joined 4SC AG as a partner in conducting a multicentre study of dominatostat/checkpoint blocker combos in treatment-naive melanoma patients.
British start-up company Mogrify Ltd (Cambridge, UK) has added US$16m from a Series A round to its US$3.7m seed financing in February 2019. Existing investor Ahren Innovation Capital led the round, with Parkwalk, 24Haymarket, and the University of Bristol Enterprise Fund III participating.